Table 1 Epidemiologic characteristics, clinical features, hospitalization, echocardiography findings, treatment modality, and outcome of 904 children with suspected SARS-CoV-2 infection
Characteristic | Value |
|---|---|
Age Median (range) | 168 (3-206) mo |
Age Group Distribution — no. (%) | |
<1 yr | 81 (9) |
1–5 yr | 416 (46) |
6–10 yr | 271 (30) |
11–15 yr | 136 (15) |
Sex — no. (%) | |
Male | 650 (72) |
Female | 254 (28) |
Diagnosis information — no. (%) | |
Confirmed Cases | 138 (15%) |
Confirmed family members | 904 (100%) |
Fever — no. (%) | 671 (74) |
Median duration of fever (range) — days | 3 (1–11) |
Diarrhea — no. (%) | 70 (7. 7) |
Sore throat— no. (%) | 91 (10.1) |
Coriza symptoms— no. (%) | 345 (38.2) |
Abdominal pain— no. (%) | 104 (11.5) |
Vomiting— no. (%) | 70 (7.75 |
Skin rash— no. (%) | 14 (1.5) |
Bacterial Superinfection | |
AOM | 20 (2.2) |
ABRS | 40 (4.4) |
Abnormalities on echocardiography Number. (%) | |
Mitral regurgitation | 21 (44.4) |
Mild Pericardial effusion | 35 (75.6) |
Tricuspid regurgitation | 17 (37.8) |
Coronary aneurysm | 9 (20) |
Myocarditis | 6 (13.3) |
Duration of hospitalization Median (range) day | 5.7 (2–13) |
Treatment | |
IVIG | 12 (21.8) |
Glucocorticoid | 41 (74.5) |
ICU Care— no. (%) | 7 (12.7) |
Intubation— no. (%) | 2 (3.6) |
Death | 2 (3.6) |
Remission | 53 (96.4) |